An anonymous reader quotes a report from The Wall Street Journal: Embattled lab-testing startup uBiome Inc. filed for bankruptcy protection Wednesday and put its assets up for sale after suspending testing of its clinical products. The San Francisco-based company filed for chapter 11 protection in U.S. Bankruptcy Court in Wilmington, Del., and said it has lined up an $8 million bankruptcy loan to keep its business open while it looks for a buyer. The company, which is under federal investigation for its billing practices, laid off around half of its global workforce in July.

UBiome had been trying to build a business on testing patients’ microbiomes based on emerging science that suggests microorganisms in the gut and other parts of the body can play a role in health. The startup had raised $83 million in a financing round from investors that included 8VC and Y Combinator. But the company has suspended the two lab tests for which it was billing insurance companies. Some of the companies had already largely or completely stopped paying claims. UBiome co-founders Jessica Richman and Zac Apte, who were earlier suspended from their positions as co-chief executives, resigned from the company’s board. In June, the board appointed Curtis Solsvig of restructuring firm Goldin Associates as acting CEO.

Read more of this story at Slashdot.

Source: Slashdot – Lab-Testing Startup uBiome Files For Bankruptcy